Literature DB >> 25439681

Towards a chemotherapy-free approach in indolent lymphoma.

Christian Buske1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25439681     DOI: 10.1016/S1470-2045(14)70488-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.

Authors:  Stefano Sacchi; Raffaella Marcheselli; Alessia Bari; Gabriele Buda; Anna Lia Molinari; Luca Baldini; Daniele Vallisa; Marina Cesaretti; Pellegrino Musto; Sonia Ronconi; Giorgina Specchia; Franco Silvestris; Luciano Guardigni; Angela Ferrari; Annalisa Chiapella; Angelo Michele Carella; Armando Santoro; Francesco Di Raimondo; Luigi Marcheselli; Samantha Pozzi
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.